Elisa Zuccarello

Development of novel phosphodiesterase 5 inhibitors for the therapy of alzheimer's disease.

Elentina K. Argyrousi, O. Arancio, D. Landry, 2020, Biochemical pharmacology.

Optimizing metabolic stability of phosphodiesterase 5 inhibitors: discovery of a potent N-(pyridin-3-ylmethyl)quinoline derivative targeting synaptic plasticity.

O. Arancio, Hong Zhang, J. Fiorito, 2023, Bioorganic & medicinal chemistry letters.

Tau is not necessary for amyloid-beta-induced synaptic and memory impairments.

Elentina K. Argyrousi, P. Fraser, O. Arancio, 2020, The Journal of clinical investigation.

Tau is not necessary for amyloid-β – induced synaptic and memory impairments

Elentina K. Argyrousi, P. Fraser, O. Arancio, 2020 .

Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade

Elentina K. Argyrousi, O. Arancio, D. Puzzo, 2019, Molecular Neurodegeneration.

Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma

G. Pitari, G. Lupo, G. Giurdanella, 2021, Journal of medicinal chemistry.